Arvinas, Inc. (ARVN): Price and Financial Metrics
ARVN Price/Volume Stats
Current price | $7.33 | 52-week high | $34.11 |
Prev. close | $7.20 | 52-week low | $5.90 |
Day low | $6.70 | Volume | 4,087,105 |
Day high | $7.44 | Avg. volume | 2,271,790 |
50-day MA | $7.41 | Dividend yield | N/A |
200-day MA | $18.19 | Market Cap | 535.02M |
ARVN Stock Price Chart Interactive Chart >
Arvinas, Inc. (ARVN) Company Bio
Arvinas Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead products include ARV-110, proteolysis targeting chimeras (PROTAC) targeting the androgen receptor (AR) protein for the treatment of men with metastatic castration-resistant prostate cancer; and ARV-471, a PROTAC targeting the estrogen receptor protein for the treatment of women with metastatic ER+ breast cancer. The company is also developing other PROTACs for degrading AR and other clinically relevant AR point mutations; and various other products for the treatment of neurodegenerative diseases, including tauopathies. Arvinas Holding Company, LLC was founded in 2015 and is based in New Haven, Connecticut.
ARVN Price Returns
1-mo | -5.05% |
3-mo | -55.63% |
6-mo | -71.13% |
1-year | -77.88% |
3-year | -83.44% |
5-year | -78.17% |
YTD | -61.76% |
2024 | -53.43% |
2023 | 20.32% |
2022 | -58.35% |
2021 | -3.29% |
2020 | 106.69% |
Continue Researching ARVN
Here are a few links from around the web to help you further your research on Arvinas Inc's stock as an investment opportunity:Arvinas Inc (ARVN) Stock Price | Nasdaq
Arvinas Inc (ARVN) Stock Quote, History and News - Yahoo Finance
Arvinas Inc (ARVN) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...